Process for the preparation of meso 2,5-dihaloadipates
AssigneePfizer Inc.
InventorsBrian T. O'Neill, Harry A. Watson, Jr.
Life of this patent
Estimating the term…
Abstract
The present process produces the meso dialkyl 2,5-dihaloadipate from a mixture of the racemic dialkyl 2,5-dihaloadipate and meso 2,5-dihaloadipate. In the disclosed process, a 2,5-dihaloadipoyl halide is formed under conditions which result in the formation of an acidic compound. The 2,5-dihaloadipoyl halide is then esterified under conditions wherein the ester of the dihaloadipoyl halide is allowed to remain in contact with the acidic compound, thus allowing the racemic diester to epimerize in the presence of the acidic compound to the meso form and then the meso diester spontaneously crystallizes. In the last stage, the meso diester produced is removed.
Claims9
A process for the preparation of the meso dialkyl 2,5-dihaloadipate from a mixture of racemic dialkyl 2,5-dihaloadiplate and meso dialkyl 2,5-dihaloadipate comprising
- (a) halogenating an adipoyl halide under conditions wherein a mixture of racemic and meso-dihalo adipoyl halides are formed, said conditions also resulting in the formation of an acidic compound,
- (b) esterifying said mixture of resultant dihalo adipoyl halides under conditions resulting in the formation of a mixture of racemic dialkyl 2,5-dihaloadipate and meso dialkyl 2,5-dihaloadipate, said conditions also resulting in the formation of an acidic compound,
- (c) allowing the mixture of (b) to remain in contact with the acidic compound produced in steps (a) and (b) for a sufficient period of time to allow spontaneous crystallization of said meso ester, said acidic compound epimerizing said racemic ester to said meso ester,
- (d) removing the meso diester thus produced from the equilibrium mixture of (b) by crystallization, whereby said crystallization of the meso diester drives the equilibrium of the mixture towards formation of the meso diester.
Dependencies are inferred from the claim text.